Rheumatic heart disease (RHD) is a long-term consequence of rheumatic fever, an inflammatory disease that can develop after a strep throat or scarlet fever infection. When left untreated, the inflammation caused by rheumatic fever can damage the heart valves, leading to complications such as valve stenosis or regurgitation. While the disease was once common in many parts of the world, its prevalence has decreased significantly in developed countries due to widespread use of antibiotics to treat strep throat. However, RHD remains a major concern in low- and middle-income nations, where access to medical care and prevention programs is limited. Early detection and appropriate treatment of streptococcal throat infections are crucial in preventing the development of rheumatic heart disease.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India